INFLIXIMAB, RECOMBINANT for Ankylosing spondylitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 20 adverse event reports in the FDA FAERS database where INFLIXIMAB, RECOMBINANT was used for Ankylosing spondylitis.

Most Reported Side Effects for INFLIXIMAB, RECOMBINANT

Side Effect	Reports	%	Deaths	Hosp.
Pneumocystis jirovecii pneumonia	29	11.4%	1	22
Off label use	21	8.2%	2	6
Infusion related reaction	18	7.1%	0	5
Histoplasmosis disseminated	16	6.3%	0	12
Tuberculosis	15	5.9%	0	0
Lupus-like syndrome	13	5.1%	1	2
Pulmonary tuberculosis	12	4.7%	0	3
Drug ineffective	11	4.3%	0	2
Pneumonia	11	4.3%	1	7
Crohn's disease	9	3.5%	0	6
Disseminated tuberculosis	7	2.8%	0	2
Immune reconstitution inflammatory syndrome	7	2.8%	0	5
Infection	6	2.4%	3	1
Drug ineffective for unapproved indication	5	2.0%	1	1
Neoplasm malignant	5	2.0%	1	1